ClinicalTrials.gg
Not yet recruitingNCT07735832REGULA-TUpdated Jul 30, 2026

Emotional Regulation and Stress Coping Program for Nursing Students During Clinical Placements

An interventional study of REGULA-T in Occupational Stress and Mental Health in Clinical Nurses, Psychological Stress and Emotional Regulation Difficulties, sponsored by Universidad Villanueva. Not yet recruiting at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-30.

Sponsored by Universidad Villanueva · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Occupational Stress with a site in Spain — 3 open to participants now, 3 under way, none of them phase 3. Occupational Stress · Spain.

Started
2026
with 2 others
No phase
8 of 10
3 open now
Registered
10th of 10
by date
Lead sponsor
1 of 10
Universidad Villanueva

Among the 10 studies in Occupational Stress with a site in Spain, this one is one of 3 that started in 2026, is one of 8 with no phase, and was the 10th registered.

Occupational Stress

238 studies on the registry are indexed under Occupational Stress; 64 are open to participants now.

Browse Occupational Stress studies →

Open to participants now

3 of the 10 studies in Occupational Stress with a site in Spain are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 33 Occupational Stress studies recruiting now, 17 (52%) set no upper age limit and 13 (39%) stop at 75 or younger; 4 take children under 18; 25 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Occupational Stress with a site in Spain, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn whether REGULA-T, a group-based emotional-skills program, improves stress coping and emotion regulation in nursing students during their clinical placements. The program is aimed at nursing students aged 18 or older enrolled in supervised clinical placements. The main questions it aims to answer are:

Does it reduce their difficulties in regulating emotions and improve their perceived emotional intelligence and coping strategies? Does the program reduce perceived stress and anxiety in students during their placements?

Researchers will compare students who take part in the REGULA-T program with students who follow the standard curriculum (waiting-list control group, who are offered the program after the study) to see whether the program improves emotional wellbeing during clinical placements.

Participants in the program will:

  • Attend a 9-session emotional-management workshop held in two modules across the academic year, timed to coincide with their clinical placements
  • Have access to an on-demand individual support service throughout the year
  • Complete online questionnaires before their placements begin and again after they finish
  • Optionally take part, after the final questionnaires, in an online group discussion about their experience

Participants in the control group will follow their standard curriculum, complete the same online questionnaires at the same two time points, and be offered the program once the study is complete.

Read the detailed description

Design and reporting standards. This is a mixed-methods study with an embedded design, comprising a prospective quasi-experimental quantitative component with two non-equivalent groups and pre-test/post-test measures, and a qualitative component. The quantitative component is reported in accordance with the TREND statement and the intervention is described following the TIDieR checklist; the qualitative component follows the COREQ criteria.

Group assignment and control of selection bias. Assignment to groups is non-random and determined by each student's voluntary decision to enrol in the program, reflecting ethical and practical constraints of the educational setting. Because initial equivalence between groups cannot be guaranteed, the design incorporates a pre-test in both groups, examines baseline comparability, and adjusts the effect estimates for pre-test scores; residual selection bias is acknowledged as a limitation.

Intervention structure. The Emotional Management Workshop is delivered face-to-face across nine sessions organised in two modules synchronised with the two placement periods. Each module alternates large-group sessions (delivered before the rotation, psychoeducational in nature) with small-group sessions (delivered during the rotation, experiential in nature). Module 1 introduces cognitive restructuring and emotion-regulation strategies; Module 2 incorporates breathing techniques for physiological deactivation and the scheduling of alternative rewarding activities; the final session provides synthesis and closure. Each session follows a common structure: review of previously assigned tasks, delivery and practice of the corresponding contents and techniques, and prescription of inter-session tasks, adapted in the first and last sessions. The workshop is complemented by an on-demand Individual Support Service (SAI) that reinforces workshop skills, allows individual recovery of large-group contents missed through justified absence, and addresses specific emotional difficulties. During the study, control-group participants may access the SAI only for emotional containment, risk assessment and referral, without delivery of program contents, preserving the integrity of the comparison condition.

Facilitator training and treatment fidelity. The workshop and the SAI are delivered by psychologists with prior training and experience in emotion-regulation and stress-management workshops, who receive standardised theoretical training on the intervention manual before implementation. Fidelity is monitored through a per-session fidelity checklist-each session being considered fidelity-adherent when at least 80% of the planned contents are covered, with deviations recorded and pending contents recovered in the following session-and through fortnightly coordination meetings with the principal investigator, with an additional meeting at the close of each module.

Qualitative component. After the post-test, three online focus groups (intervention students, control students, and clinical tutors) will be conducted by a moderator not involved in delivering the intervention, using a profile-specific semi-structured topic guide. Sessions will be recorded and transcribed verbatim and analysed through reflexive inductive thematic analysis, with independent coding by two researchers and resolution of discrepancies by consensus.

Analysis. Quantitative analyses (IBM SPSS Statistics v24) will follow an intention-to-treat approach, keeping participants in their original allocation group regardless of SAI use. Effect estimates will be obtained through complementary between-group (post-test) and within-group (pre-post) comparisons, reporting effect sizes with 95% confidence intervals. SAI use will be recorded for the whole sample and treated as a co-intervention in pre-specified sensitivity analyses; a per-protocol analysis restricted to adherent participants will also be conducted. Quantitative and qualitative findings will be integrated through triangulation during interpretation.

03

Conditions studied

  • Occupational Stress and Mental Health in Clinical Nurses
  • Psychological Stress
  • Emotional Regulation Difficulties

Keywords

  • nursing students
  • clinical placement
  • emotion regulation
  • stress coping
  • psychoeducational intervention
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged ≥18
  • Enrolled in Clinical Placements I or II of the Nursing Degree at Universidad Villanueva
  • Signed (intervention group also signs an attendance commitment

Qualitative - clinical tutors:

  • Registered nurses currently or previously supervising nursing students
  • Informed consent

Exclusion criteria

Exclusion Criteria:

  • Language difficulties precluding correct comprehension of the instruments
  • Diagnosis of a severe mental disorder
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    REGULA-T intervention group

    Participants in this arm receive the REGULA-T program during their clinical placements.

    Behavioral: REGULA-T

  • No intervention
    Waitlist control group

    Standard curricular follow-up; access to the program after the posttest.

Interventions

  • BehavioralREGULA-T

    Group-based Emotional Management Workshop (9 sessions, two modules; large-group sessions ≈17 participants, small-group sessions ≈8) plus on-demand Individual Support Service (SAI)

06

What researchers measure

Primary outcomes

  1. Perceived stress (PSS-10)

    Perceived stress over the past month, measured by the 10-item Perceived Stress Scale (score range 0-40; higher scores indicate greater perceived stress)

    Time frame: From enrollment to the end of the intervention at 9 months

  2. Coping strategies (CRI-A)

    Coping Responses Inventory-Adult Form. The inventory comprises 48 items rated on a 4-point scale, grouped into eight subscales (each scored from 0 to 18) that form two dimensions: Approach Coping and Avoidance Coping. Higher scores on approach coping subscales indicate greater use of adaptive coping strategies (better outcome); higher scores on avoidance coping subscales indicate greater use of avoidant strategies (worse outcome).

    Time frame: From enrollment to the end of the intervention at 9 months

  3. Perceived emotional intelligence (TMMS-24)

    Trait Meta-Mood Scale-24. The scale comprises 24 items rated on a 5-point Likert scale across three subscales (Attention, Clarity, and Repair), each scored from 8 to 40. Higher scores indicate greater perceived emotional intelligence (better outcome).

    Time frame: From enrollment to the end of the intervention at 9 months

  4. Emotion regulation difficulties (DERS)

    Difficulties in Emotion Regulation Scale. The Spanish version comprises 28 items rated on a 5-point Likert scale, with total scores ranging from 28 to 140. Higher scores indicate greater difficulties in emotion regulation (worse outcome).

    Time frame: From enrollment to the end of the intervention at 9 months

  5. State-trait anxiety (STAI)

    State-Trait Anxiety Inventory. The scale comprises two 20-item subscales (State Anxiety and Trait Anxiety), each scored from 0 to 60. Higher scores indicate greater anxiety (worse outcome).

    Time frame: From enrollment to the end of the intervention at 9 months

Secondary outcomes

  1. Treatment satisfaction

    Participant satisfaction with the program, measured by a Treatment Satisfaction Questionnaire (higher scores indicate greater satisfaction).

    Time frame: At the end of the intervention, 9 months from enrollment

  2. Participants' and tutors' experiences (focus groups)

    Qualitative exploration of emotional competence, stress-coping strategies, and support needs through three online focus groups (intervention students, control students, clinical tutors), analysed by thematic analysis.

    Time frame: After completion of the intervention, up to 10 months from enrollment

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Jul 2027, 9 months later.

Of 128 non-industry interventional studies with no phase under Occupational Stress, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 27. This study's planned 9 months is close to that.

Counting every sponsor, half of 136 studies reached it within 10 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 21, 2026
First posted
Jul 30, 2026
StartEst.
Sep 15, 2026
Primary completionEst.
Jul 1, 2027
CompletionEst.
Jul 1, 2027
Last update
Jul 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07735832
Lead sponsor
Universidad Villanueva
Responsible party
Begona Haro (Associate Professor, Universidad Villanueva) — Principal investigator
First posted
Jul 30, 2026
Start date
Sep 15, 2026 (estimated)
Primary completion
Jul 1, 2027 (estimated)
Completion
Jul 1, 2027 (estimated)
Last update
Jul 30, 2026

Study contacts

Begona Haro, PhD
Contact
begona.haro@unavarra.es
+34917340413
Begoña Haro, Doctor
principal investigator · Universidad Villanueva
Belén Aguilar
study director · Universidad Villanueva

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion